Authors:
Cursiefen, S
Flachenecker, P
Toyka, KV
Rieckmann, P
Citation: S. Cursiefen et al., Escalating immunotherapy with mitoxantrone in patients with very active relapsing-remitting or progressive multiple sclerosis, EUR NEUROL, 43(3), 2000, pp. 186-187
Authors:
Buttner, U
Chofflon, M
Hess, K
Kappos, L
Kesselring, J
Ludin, H
Rihs, F
Schluep, M
Vaney, C
Baumhackl, U
Berger, T
Freimuller, O
Hartung, HP
Kollegger, W
Kristoferitsch, W
Vass, K
Lassmann, H
Markut, S
Altenkirch, H
Boese, J
Gehlen, W
Goebels, N
Gold, R
Haas, J
Haferkamp, G
Heidenreic, F
Heitmann, R
Hohlfeld, R
Jugelt, E
Kolmel, H
Konig, N
Lowitzsch, K
Manegold, U
Mertin, J
Pette, M
Poser, S
Sailer, J
Schack, G
Schulz, M
Seidel, D
Stark, E
Stoll, G
Weinrich, W
Wietholter, H
Zettl, U
Zipp, F
Zschenderlein, R
Rieckmann, P
Toyka, KV
Chan, A
Bayas, A
Maurer, M
Jung, S
Gold, R
Weilbach, F
Cursiefen, S
Flachenecker, P
Rieckmann, P
Citation: U. Buttner et al., Escalating immunomodulatory therapy of multiple sclerosis, NERVENARZT, 70(4), 1999, pp. 371-386
Authors:
Cursiefen, S
Flachenecker, P
Rieckmann, P
Toyka, KV
Citation: S. Cursiefen et al., Mitoxantrone in the treatment of severe multiple sclerosis (vol 70, pg 723, 1999), NERVENARZT, 70(12), 1999, pp. 1051-1051